246710 — T&R Biofab Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual income statement for T&R Biofab Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,287	6,805	3,235	5,755	5,199
Cost of Revenue
Gross Profit	609	2,659	-212	1,542	1,077
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	8,147	12,314	13,662	13,798	18,743
Operating Profit	-6,860	-5,509	-10,428	-8,043	-13,544
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-6,251	-5,604	-11,083	-10,337	-13,419
Provision for Income Taxes
Net Income After Taxes	-6,251	-5,604	-11,083	-10,337	-13,419
Net Income Before Extraordinary Items
Net Income	-6,251	-5,604	-11,083	-10,337	-13,419
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-6,251	-5,604	-11,083	-10,337	-13,419
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-377	-334	-613	-728	-594
Dividends per Share